Physician profile
Keith A Glowacki
NPI 1285600486
$4,291.02
in general payments reported to CMS, 2019-2025
9 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $12.68 · 2022: $1,200 · 2023: $2,668 · 2024: $71.45 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,180 · Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,179.66 |
| Food and Beverage | $756.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fortis Surgical, LLC | $1,989.68 | 2022-2025 | |
| Axogen | $1,817.73 | 2023 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Arthrex, INC. | $186.40 | 2023 | |
| Zimmer Biomet Holdings, INC. | $116.58 | 2019 | |
| Stryker Corporation | $105.44 | 2024-2025 | Conextions Tr Tendon Repair System-Implant Mechanism, Variax |
| Integra Lifesciences Corporation | $32.14 | 2020-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Alafair Biosciences, INC. | $17.35 | 2024 | Versawrap |
| Bioventus LLC | $13.59 | 2019 | |
| Linvatec Corporation | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Glowacki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.